CAPA serves as the engine of a high-performance Pharmaceutical Quality System (PQS). It shifts quality management from reactive "firefighting" to a results-oriented strategy that optimizes processes across manufacturing and the global supply chain. Authorities such as the FDA, WHO, EMA, and CDSCO require a robust CAPA system. During GMP inspections, your CAPA records tell the story of your quality culture and your commitment to operational excellence.

In today's highly regulated nutraceutical market, packaging is no longer just about attractive design it is a legal document. Every colour, font, symbol, declaration, warning statement, nutrition panel, and health claim printed on a nutraceutical label is regulated under the Food Safety and Standards Authority of India (FSSAI). A beautifully designed package that fails to meet regulatory requirements can lead to product recalls, rejected consignments, penalties, import issues

This June 2026 notification signals a maturing pharmacovigilance framework. For stakeholders from large-scale manufacturers and CMOs to frontline healthcare providers, the message is clear: scientific justification is the only path to market survival. This article breaks down the ban and explores the strategic shifts necessary for industry compliance.

Navigate the distinct roles of CDSCO and State FDA to ensure faster approvals, full compliance, and successful market entry. 1....